Multicentric cancer of the breast
Letiagin, V.P.; Podviaznikov, S.O.
Voprosy Onkologii 33(8): 55-58
1987
ISSN/ISBN: 0507-3758 PMID: 3630032 Document Number: 300076
Multicentric breast carcinoma was identified in 3.7% of 119 patients operated on at the Center Clinics. A slow growth, small size of tumors and infrequent lesions in the regional lymph nodes were registered. A correlation between the degree of malignancy and the number of tumor nodes in breast tissues was established. The best end results--a survival rate of 16.8% at 10 years--were obtained after radical mastectomies. A classification of multicentric breast cancers is suggested.
Document emailed within 1 workday
Related Documents
Spanu, A.; Cottu, P.; Manca, A.; Chessa, F.; Sanna, D.; Madeddu, G. 2007: Scintimammography with dedicated breast camera in unifocal and multifocal/multicentric primary breast cancer detection: a comparative study with SPECT International Journal of Oncology 31(2): 369-377Kokhreidze, I. 2017: Oncoplastic Surgery of Multicentric (Multifocal) Breast Cancer (Case Report) Georgian Medical News 2017(272): 7-12
Malik, S.S.; Baig, M.; Khan, M.B.; Masood, N. 2019: Survival analysis of breast cancer patients with different treatments: a multicentric clinicopathological study JPMA. Journal of the Pakistan Medical Association 69(7): 976-980
Lang, Z.; Wu, Y.; Pan, X.; Qu, G.; Zhang, T. 2018: Study of differential gene expression between invasive multifocal/ multicentric and unifocal breast cancer Journal of BUON: Official Journal of the Balkan Union of Oncology 23(1): 134-142
Lipkus, I.M.; Iden, D.; Terrenoire, J.; Feaganes, J.R. 1999: Relationships among breast cancer concern, risk perceptions, and interest in genetic testing for breast cancer susceptibility among African-American women with and without a family history of breast cancer Cancer Epidemiology Biomarkers and Prevention: a Publication of the American Association for Cancer Research Cosponsored by the American Society of Preventive Oncology 8(6): 533-539
1997: Pathology of familial breast cancer: differences between breast cancers in carriers of BRCA1 or BRCA2 mutations and sporadic cases. Breast Cancer Linkage Consortium Lancet 349(9064): 1505-1510
Vidu, V.; Hortopan, M.; Aldea, C.; Liscu, B.; Popovici, A. 2000: A case of intraductal multicentric breast carcinoma with bilateral axillary metastases Chirurgia 95(6): 543-547
Feinauer, B.; Jacob, H.; Maier, K. 1981: Multicentric early cancer of the stomach Zeitschrift für Gastroenterologie 19(2): 68-76
Reiner, A.S.; Sisti, J.; John, E.M.; Lynch, C.F.; Brooks, J.D.; Mellemkjær, L.; Boice, J.D.; Knight, J.A.; Concannon, P.; Capanu, M.; Tischkowitz, M.; Robson, M.; Liang, X.; Woods, M.; Conti, D.V.; Duggan, D.; Shore, R.; Stram, D.O.; Thomas, D.C.; Malone, K.E.; Bernstein, L.; Bernstein, J.L. 2018: Breast Cancer Family History and Contralateral Breast Cancer Risk in Young Women: An Update From the Women's Environmental Cancer and Radiation Epidemiology Study Journal of Clinical Oncology: Official Journal of the American Society of Clinical Oncology 36(15): 1513-1520
Nabholtz, J.M.; Lindsay, M.A.; Hugh, J.; Mackey, J.; Smylie, M.; Au, H.J.; Tonkin, K.; Allen, M. 1999: The academic global virtual concept in clinical cancer research and its application to breast cancer: The Breast Cancer International Research Group Seminars in Oncology 26(3 Suppl. 8): 4-8
Albeshan, S.M.; Hossain, S.Z.; Mackey, M.G.; Brennan, P.C. 2020: Can Breast Self-examination and Clinical Breast Examination Along with Increasing Breast Awareness Facilitate Earlier Detection of Breast Cancer in Populations with Advanced Stages at Diagnosis? Clinical Breast Cancer 20(3): 194-200
Maassen, V.; Debus-Thiede, G. 1993: Serous papillary cancer of the peritoneum: a multicentric primary disease Zentralblatt für Gynakologie 115(8): 347-354
Stamatovic, L.; Susnjar, S.; Gavrilovic, D.; Minic, I.; Ursulovic, T.; Dzodic, R. 2018: The influence of breast cancer subtypes on the response to anthracycline neoadjuvant chemotherapy in locally advanced breast cancer patients Journal of Buon: Official Journal of the Balkan Union of Oncology 23(5): 1273-1280
Rosenberg, L.; Palmer, J.R.; Shapiro, S. 1992: Oestrogen replacement therapy and breast cancer Results from the Slone Epidemiology Units Toronto Breast Cancer Study Mann, R D Hormone replacement therapy and breast cancer risk : 253-264
Mariuzzi, L.; Mombello, A.; Rucco, V.; Morelli, L.; Zamò, A.; Thompson, D.; Vaught, L.; Bartels, H.G.; Mariuzzi, G.; Bartels, P.H. 2000: Quantitative study of ductal breast cancer progression: signatures of nuclei in proliferating breast lesions and in situ cancer Advances in Clinical Pathology: the Official Journal of Adriatic Society of Pathology 4(2): 87-97
Tokuda, Y. 2014: The Japanese Breast Cancer Society Breast Cancer Registry in the National Clinical Database: current status and future perspectives Nihon Geka Gakkai zasshi 115(1): 17-21
Chagpar, A.B. 2007: Insights into the management of locally advanced, inflammatory, and metastatic breast cancer: highlights from the 2007 Louisville Breast Cancer Update Journal of the Kentucky Medical Association 105(11): 559-560
Crivellari, D. 2002: Results of adjuvant treatments in breast cancer patients over 70 years old: the IBCSG experience. International Breast Cancer Study Group Tumori 88(1 Suppl. 1): S81-S82
Lundin, A.C.; Söderkvist, P.; Eriksson, B.; Bergman-Jungeström, M.; Wingren, S. 1999: Association of breast cancer progression with a vitamin D receptor gene polymorphism. South-East Sweden Breast Cancer Group Cancer Research 59(10): 2332-2334
Andersen, J.; Nielsen, M.; Christensen, L.; Ottesen, G.L.; Blichert-Toft, M. 1987: The significance of the frequency and occurrence of breast cancer for treatment. Essential aspects of new Danish studies of the natural history of breast cancer Acta Chirurgica Belgica 87(2): 103-107